![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1 Medications – Community Education](https://ars.els-cdn.com/content/image/1-s2.0-S0001731023008505-fx1.jpg)
glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1 Medications – Community Education
Description
Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1 Medications Community Education](https://blogs.cornell.edu/communityeducation/files/2025/09/GLP.jpg)
Tirzepatide typically produces far more than 5-10% weight loss
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1 Medications Community Education](https://jcadonline.com/wp-content/uploads/Cotter2_Table2.gif)
The primary endpoint is change in FTND score from baseline, assessed at weeks 1, 4, 8, 12, and 24
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1 Medications Community Education](https://i.ytimg.com/vi/b_QTw69lPFw/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLDNekNubi9EQeozlPqzP-TJgII_dg)
Both semaglutide and tirzepatide affect appetite, blood sugar, and food relationships in similar ways
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1 Medications Community Education](https://jddonline.com/wp-content/uploads/2025/04/JDD-BLOG-IMAGE-TEMPLATE-2.png)
Ozempic was submitted to the FDA for the treatment of patients with T2DM and peripheral artery disease (PAD)
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases GLP-1 Medications Community Education](https://assets.cureus.com/uploads/figure/file/1314190/article_river_58859fd0ab6a11efafceffcdd999c5f2-WhatsApp-Image-2024-11-25-at-9.20.11-AM.png)
